Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Reports outline immunization study findings from A. Ramezani and colleagues
March 18th, 2009
According to recent research published in the International Journal of Clinical Practice, "Hepatitis B vaccine is effective in protection against hepatitis B virus (HBV) infection in haemodialysis (HD) patients, but the antibody response is variable in this population and the persistence of immunity in them remains largely unknown. In this study we aimed to evaluate the efficacy and long-term immunogenicity of hepatitis B vaccine in HD patients." "In this study, we initially offered HBV vaccination as double dose, four vaccine series schedule (40 mu g injections intramuscularly in the deltoid muscle at 0, 1, 2 and 6 months) to 54 HD patients who were negative for...
Source: Vaccine Weekly (2009-03-18)
|
